drugs

HHS released a proposed rule outlining changes it wishes to make to the 340B administrative dispute resolution process.

A new study says drug companies reduce access to care by limiting 340B community pharmacies.

In the second of a two-part interview, Brian Clear MD, chief medical officer of Bicycle Health, talks about treatment details...

A decade-long process to secure the safety and security of the pharmaceutical supply chain is nearing the finish line.

Forty-four percent of hospitals view the 340B Drug Pricing Program as a critical revenue source.

Researchers have compared Medicare Part D generic drug pricing with pricing at the Mark Cuban Cost Plus Drug Company.

Congress, purchasers, and industry analysts weighed in on the role pharmacy benefit managers play in prescription drug costs.

Clinical trial innovation must be patient-centered, inclusive, and tech-enabled.

One Michigan plan is bringing predictive power to patient drug treatment.

Dr. Alison Lum explains why fixing a complex ecosystem is possible but requires all stakeholders.

The new law allows providers to use telemedicine to prescribe most controlled substances, as long as they meet federal guidelines....

Health systems like Magnolia Regional Health Center are boosting patient engagement and reducing wasted prescriptions with new services at the...